Literature DB >> 16920752

Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab.

A Kuek, B L Hazleman, J H Gaston, A J K Ostör.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16920752     DOI： 10.1093/rheumatology/kel301

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  17 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  A successful treatment of juvenile idiopathic arthritis with rituximab: A report of two cases.

Authors:  Khadija Berrada; Fatima Ezzahra Abourazzak; Imane El Mezouar; Faiza Lazrak; Nacira Aradoini; Latifa Tahiri; Taoufik Harzy
Journal:  Eur J Rheumatol       Date:  2014-12-01

4.  Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis.

Authors:  Ekaterina I Alexeeva; Saniya I Valieva; Tatyana M Bzarova; Elena L Semikina; Kseniya B Isaeva; Alexander O Lisitsyn; Rina V Denisova; Evgeniya G Chistyakova
Journal:  Clin Rheumatol       Date:  2011-03-08       Impact factor: 2.980

Review 5.  The safety profile of biologic therapies for juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Yosef Uziel; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2010-08-31       Impact factor: 20.543

Review 6.  Biologics in juvenile idiopathic arthritis: a narrative review.

Authors:  Federica Vanoni; Francesca Minoia; Clara Malattia
Journal:  Eur J Pediatr       Date:  2017-07-20       Impact factor: 3.183

7.  [B-cell targeted therapy for children and adolescents with rheumatic diseases].

Authors:  H Morbach; H J Girschick
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

8.  Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis.

Authors:  Anna Corcione; Francesca Ferlito; Marco Gattorno; Andrea Gregorio; Angela Pistorio; Roberto Gastaldi; Claudio Gambini; Alberto Martini; Elisabetta Traggiai; Vito Pistoia
Journal:  Arthritis Res Ther       Date:  2009-10-05       Impact factor: 5.156

Review 9.  Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.

Authors:  Kristen Hayward; Carol A Wallace
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

10.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.